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Field of the Invention
[0001] The present invention relates to tomato-derived fractions for adding and/or enhancing umami taste and to
methods of preparing such fractions. The invention also relates to the use of these tomato-derived fractions in foodstuffs
and beverages.
Background of the Invention
[0002] The tongue is sensitive to five tastes: salt, sweet, bitter, sour, and "umami" in Japanese language, the taste of
glutamate. There is no analogous word to describe this taste quality in the English language. "Umami" is used by the
Japanese to describe the taste of monosodium glutamate (MSG, the sodium salt of the amino acid glutamic acid) as
well as the taste of ripe tomatoes or the meaty taste of certain fish and broth. It should be noted that although glutamate
is often referred to as flavour enhancer, this is probably incorrect as the umami taste is a taste on its own.
[0003] Monosodium glutamate (also know as Ve-Tsin or E621) is a controversial additive. However, clinical studies
have so far given no reasons for concern. Hence, whereas MSG or glutamate can actually aid to providing healthier
eating habits, consumer acceptance is generally low, even despite the proven safety of MSG. There is thus a need for
umami-active compositions that are label friendly or that do not have to be mentioned on the labels at all.
[0004] One such composition has been described in WO 99/60868, which relates to a clear tomato concentrate
comprising hydrolyzed tomato proteins. The clear tomato concentrate of WO 99/60868 is produced by processing
tomatoes into two fractions, the serum and the pulp, and concentration of the serum to a value of e.g. 80 Brix, followed
by hydrolysis (enzymatic or acid) of the concentrated serum. In an alternative embodiment, the serum is first hydrolyzed
and then concentrated. The so obtained clear tomato concentrate may subsequently be dried.
[0005] WO 2008/040611 describes a method of producing a fractionated tomato extract having a pH of at least 4.6,
when having a Brix value of 1.0; comprising 2.5-95 wt% of glutamic acid, based on the dry weight thereof; having a
weight ratio of total glutamic acid to citric acid of at least 0.8 and a lycopene level of below 50 ppm, based on the dry
weight of the extract, said process comprising the subsequent steps of preparing tomato serum and hydrolysing the
proteins contained in the tomatoes from which the serum is prepared; subsequently fractionating the serum into two or
more fractions, one fraction being rich in glutamic acid and low in citric acid and lycopene. The tomato fraction contains
increased amounts of gamma-aminobutyric acid (GABA). Sugars, in particular the monosaccharides glucose and fruc-
tose, are considered to enhance the umami taste, and are kept within specific limits of monosaccharide to glutamic acid
ratio.
[0006] WO 2009/080763 and WO 2010/079013 describe processes for producing an umami-active tomato fraction,
involving the subsequent steps of providing a tomato serum, preferably substantially free from sucrose; separating the
serum into two or more portions: at least one first portion and at least one second portion whereby the at least one first
portion is lower in lycopene than the at least one second portion; concentrating the at least one first portion low in
lycopene; fractionating the lycopene-depleted concentrated serum into fractions with well-defined w/w ratio of citric acid
to glutamic acid (C/Glu). The umami-active tomato fractions obtained in ’763 and ’013 are characterized by comprising
relative high levels of glucose and/or fructose and low levels of glutamic acid, and have glucose to glutamic acid ratios
in excess of 4.
[0007] WO 2010/069743 relates to a liquid umami-enhancing composition for use in food products having very low
levels of glutamic acid while maintaining an umami taste perception similar to products with normal levels of glutamic
acid. The composition is characterized by a w/w ratio of glutamic acid to citric acid of at most 0.6 and comprises at most
2 wt% of glutamic acid.
[0008] The above-described methods suffer from the drawbacks that they produce a rather crude umami fraction
and/or that the fractionation process is inefficient.
Summary of the invention
[0009] The inventors have developed a very efficient method for producing a high quality umami-active tomato fraction,
said process comprising the steps of:
a. providing a tomato serum;
b. separating the tomato serum into at least a lycopene-depleted portion and a lycopene-enriched portion;
c. concentrating the lycopene-depleted portion;
d. chromatographically fractionating the concentrated lycopene-depleted portion into at least two fractions, including
a crude umami-rich fraction and a monosaccharide-rich fraction;













e. optionally, concentrating the crude umami fraction;
f. chromatographically fractionating the crude umami fraction into at least two fractions, including a clean umami
fraction and a citrate fraction.
[0010] The present invention comprises at least two chromatographic fractionation steps for producing umami fractions,
wherein the earlier fractionation step involves removing a major amount of the monosoaccharides from a lycopene-
depleted portion of tomato serum to produce a crude umami fraction. The monosaccharide-depleted crude umami fraction
is then subjected to another chromatographic fractionation step for removal of citrate. The process of the invention
provides an efficient and economical means of preparing a high quality umami extract from tomato.
[0011] The invention also provides a tomato isolate comprising 0-90 wt.% water and 10-100 wt.% dry matter, said dry
matter comprising:
• 3-40 wt.% glutamate;
• 0-8 wt.% 5’-adenosine monophosphates (5’-AMP);
• 1-25 wt.% aspartate;
• 0-20 wt.% citrate;
• 0-10 wt.% monosaccharides;
• 0.1-15 wt.% sucrose; and
wherein the weight ratio glutamate:citrate exceeds 2 and wherein glutamate, 5’-AMP, aspartate and pyroglutamate
together represent at least 15 wt.% of the dry matter contained in the tomato isolate.
[0012] The aforementioned glutamate-rich tomato isolate can suitably be used to impart umami taste to foodstuffs
and beverages.
Detailed description of the invention
[0013] In a first aspect, the invention pertains to a method for producing an umami-active tomato fraction comprising
the steps of:
a. providing a tomato serum having a total solids content of 0.05-30 wt.%;
b. separating the tomato serum into two or more portions, including a lycopene-depleted portion and a lycopene-
enriched portion, the lycopene content of the lycopene-depleted portion being less than 30% of that of the lycopene-
enriched portion, both said lycopene contents being calculated on dry matter;
c. concentrating the lycopene-depleted portion to at least 10°Brix;
d. chromatographically fractionating the concentrated lycopene-depleted portion into two or more fractions, including
a crude umami fraction with a weight ratio glutamate:monosaccharide of X and a monosaccharide fraction with a
weight ratio glutamate:monosaccharide of Y, wherein the ratio X:Y exceeds 20;
e. optionally, concentrating the crude umami fraction;
f. chromatographically fractionating the crude umami fraction into two or more fractions, including a clean umami
fraction with a weight ratio glutamate:citrate of K and a citrate fraction with a weight ratio glutamate:citrate of L,
wherein the ratio K:L exceeds 10.
[0014] The term "tomato serum" as used herein refers to a liquid that can be obtained from tomato paste or tomato
juice by removing particles therefrom, e.g. by centrifugation or filtration.
[0015] The terminology "chromatographically fractionating" as used herein refers to a procedure in which a composition
is fractionated by passing it as (part of) a mobile phase through a structure, e.g. a column, holding a stationary phase
and by collecting the effluent in different portions.
[0016] The term "ion exclusion chromatography" as used herein refers to a form of ion exchange chromatography in
which the mobile ions in the resin-gel phase electrically neutralize the immobilized charged functional groups attached
to the resin, thus preventing penetration of solvent electrolyte into the resin-gel phase.
[0017] The term "Brix value" which is considered to be synonymous to the term Degrees Brix (symbol °Bx or °Brix) is
an indirect measurement of the amount of dry matter. It is a measure of the percent total soluble solids in a given weight
of plant juice, which includes the summation of sucrose glucose, fructose, vitamins, amino acids, protein, and any other
soluble solids. It is often expressed as the percentage of sucrose. It is measured with a refractometer with a Brix scale.
[0018] The terms "glutamic acid" and "glutamate" are commonly used to refer to the protonated and the deprotonated
solubilised form of the same acid, respectively. In addition glutamate is commonly used to refer to salts of the free acid.
For the sake of convenience, the term "glutamate" as used herein, unless indicated otherwise, encompasses glutamic
acid, salts of glutamic acid and combinations thereof.













[0019] Likewise, the terms "citrate", "aspartate", "malate" and "pyroglutamate" as used herein, unless indicated oth-
erwise, encompass both the protonated and deprotonated forms of these acids.
[0020] The terms "comprising" and "containing" whenever used in this document is intended to indicate the presence
of stated features, integers, steps, components, but not to preclude the presence or addition of one or more other
features, integers, steps, components or groups thereof.
[0021] Typically, the tomato serum employed in the present method contains less than 1 wt.%, more preferably less
than 0.5 wt.% and most preferably less than 0.1 wt.% particles having a diameter of 100 mm or more. The tomato serum
optionally has been concentrated to a Brix value of not more than 60°Brix.
[0022] The tomato serum that is employed as a starting material in the present process may suitably be obtained by
a process comprising the steps of:
• comminuting and/or macerating tomatoes to produce a pumpable mass; and
• separating the pumpable mass, optionally after dilution or concentration, into serum and pulp by means of a centrifugal
separator (e.g. a decanter).
[0023] According to a preferred embodiment the comminuting and/or macerating of the tomatoes is carried out in a
chopper pump, wherein the tomatoes are pressed through square holes, typically 1-2 cm in diameter.
[0024] In a particularly advantageous embodiment, heat is applied prior to, during or after the comminuting and or
macerating of the tomatoes. Preferably, the amount of heat applied is such that the tomatoes reach a temperature of
above 80 °C. This process is generally referred to as hot break.
[0025] In accordance with a preferred embodiment of the invention seeds and skin are removed from the pumpable
mass, typically by sieving using perforated screens or the like, prior to the separation.
[0026] Optionally, the serum so obtained may be clarified by micro filtration, so as to remove undissolved solids.
[0027] In the present method the serum is separated into two or more portions, including a lycopene-depleted portion
and a lycopene-enriched portion, the lycopene content of the lycopene-depleted portion being less than 20 wt%, preferably
less than 15% and most preferably less than 5% of that of the lycopene-enriched portion, both said lycopene contents
being calculated on dry matter.
[0028] The lycopene content of the lycopene-depleted portion typically is less than 20 mg per kg of dry matter, more
preferably less than 10 mg per kg of dry matter, even more preferably less than 5 mg per kg of dry matter, and most
preferably less than 3 mg per kg of dry matter.
[0029] The serum used as starting material for this separation step may be processed in undiluted form or alternatively
it may have been concentrated before further processing in the separation step. Preferably, the serum has been con-
centrated prior to the separation step. The tomato serum may be concentrated by removing at least part of the water
content e.g. under reduced pressure and/or increased temperature. Preferably the concentration is performed using a
falling film evaporator, spinning column evaporator or plate evaporator, although entirely different systems are available
and can be used without departing from the scope of the invention.
[0030] The tomato serum that is employed in the separation step typically has Brix value of at least 3° Brix, more
preferably at least 5° Brix. According to a particularly preferred embodiment prior to the separation step the tomato
serum has been concentrated to a Brix value of at least 10° Brix, more preferably at least 20° Brix. Typically the Brix
value of the serum does not exceed 50° Brix, more preferably it does not exceed 40° Brix.







• 0.1-3% 5’-adenosine monophosphate (5’- AMP);
• 0.001-0.05% lycopene;
• 0-30% of other tomato components.
[0032] The separation of the tomato serum preferably comprises micro-filtering and/or ultra-filtrating the serum to
produce a lycopene-depleted portion as the permeate and a lycopene-enriched portion as the retentate. The micro-
filtering of the serum preferably comprises passing the serum through a micro-filter having a pore-size of less than 10mm.
The ultra-filtering of the serum preferably comprises passing the serum through a membrane with a molecular weight
cut off of not more than 250 kDa, more preferably of not more than 200 kDa, even more preferably of not more than 150 kDa.
[0033] For the ultra filtration, any suitable membrane may be used. An example of a suitable membrane is an Alfa-













Laval polysulphone membrane with 100 kDa molecular weight cut-off (GR40PP).
[0034] The lycopene-depleted portion typically comprises less than 5 ppm of particles of at least 10 mm, more preferably
less than 3 ppm of particles of at least 10 mm, even more preferably less than 1 ppm of particles of at least 10 mm.







• 0.1-3% 5’-adenosine monophosphate (5’- AMP);
• 0-30% of other tomato components.
[0036] The lycopene-depleted portion is suitably concentrated to at least 10° Brix before it is subjected to chromato-
graphic separation. Even more preferably, the lycopene-depleted portion is concentrated to a Brix value of 20-60 °Brix.
[0037] The concentrated lycopene-depleted portion obtained from the separation step is chromatographically frac-
tionated into two or more portions, including a crude umami fraction with a weight ratio glutamate:monosaccharide of X
and a monosaccharide fraction with a weight ratio glutamate:monosaccharide of Y, the ratio X:Y preferably exceeding
40, more preferably exceeding 100 and most preferably exceeding 500.
[0038] Chromatographic fractionation of the lycopene-depleted portion is preferably achieved by using ion exclusion
chromatography, whereby the chromatographic separation medium is an ion exchange resin.
[0039] Suitable ion exchange resins include DIAION™ UBK-530 and UBK-550 (each of which is produced by Mitsubishi
Chemical Corporation). Preferred resins are negatively charged (and thereby capable of strong repulsion of negatively
charged compounds). Especially preferred is UBK-530, a strong acid cation resin containing, as a base material, poly-
styrene-divinyl benzene gel (produced by MITSUBISHI CHEMICAL CORP.; Na+-type; average particle size: 200 to 240
mm; exchange capacity: 1.6 meq/ml).
[0040] Any appropriate solvent may be used as eluent during the chromatographic fractionation, but water is preferred.
Even more preferred, the eluent employed in the present process is demineralised water. More preferred is water purified
by, for example, reverse osmosis (e.g. MilliQ). In other words, it is preferred to employ an eluens that does not contain
a buffer.
[0041] The present invention offers the advantage that it enables the isolation of an umami-active tomato fraction
without using organic solvents. Thus, in accordance with a particularly preferred embodiment of the invention no organic
solvents are used in the present method.
[0042] Applicants have found that the fractionation is more robust and cost-effective when it is carried out at elevated
temperatures. The chromatographic fractionation is preferably carried out at a temperature of at least 40 °C, preferably
at least 50 °C, more preferably at least 60 °C. Typically, the chromatographic fractionation is carried out at a temperature
that does not exceed 105 °C.
[0043] The inventors have unexpectedly discovered that the separation efficiency of the ion exchange resins used in
the present method can be maintained for a much longer period of time if prior to subjecting the lycopene-depleted
portion to ion exclusion or ion exchange chromatography, the multivalent metal cation content of said portion is reduced
substantially.
[0044] Hence, according to a particularly preferred embodiment of the invention, prior to the chromatographic frac-
tionation, the concentrated lycopene-depleted portion is treated to reduce the total amount of calcium (Ca2+) and mag-
nesium (Mg2+) ions, calculated on dry matter, with at least a factor 4, preferably at least a factor 8 and most preferably
at least a factor 16.
[0045] Although the inventors do not wish to be bound by theory, it is believed that the divalent cations Ca2+ and Mg2+
can reduce the number of available charges of the ion exclusion resin by forming stable bridges between adjacent
negatively charged resin groups, thereby impairing the ion exclusion ability of the resin bed. As the adsorption of these
divalent cations by the resin progresses, chromatographic resolution of charged and neutral compounds will increasingly
deteriorate. Thus, reduction of the multivalent ion content of the lycopene-depleted portion greatly improves the efficiency
of chromatographic separation of glutamate and monosaccharides during the first chromotagraphic separation step.
[0046] Examples of techniques that may suitably be used for selectively removing Ca2+ and Mg2+ from the concentrated
lycopene-depleted serum portion include electrodialysis, nanofiltration, ion exchange chromatography or combinations
thereof. Preferably, ion exchange chromatography is used.
[0047] The lycopene-depleted portion is preferably treated to reduce the total amount of calcium and magnesium ions
to less than 50 mmol, more preferably less than 20 mmol and most preferably less than 10 mmol per kg of dry matter.
Advantageously, the removal of Ca2+ and Mg2+ is carried out in such a way that the composition of the bulk remains













largely unaffected. Preferably, at least 90 wt.%, more preferably at least 95 wt.% and most preferably at least 99 wt.%
of the dry matter contained in the lycopene depleted composition is unaffected by the removal of the calcium and
magnesium ions.
[0048] Typically, in the present method at least 60% of the glutamate, more preferably at least 80% of the glutamate
contained in the lycopene-depleted portion is recovered in the crude umami fraction that is obtained from the first
chromatographic separation step.
[0049] The weight ratio X (glutamate:monosaccharide) in the crude umami fraction obtained by chromatographic
fractionation of the concentrated lycopene-depleted portion typically is at least 3, preferably at least 5 and most preferably
at least 10.
[0050] The crude umami fraction typically has a weight ratio citrate:monosaccharide of at least 1, more preferably of
at least 3 and most preferably of at least 10.
[0051] Preferably, the crude umami fraction contains at least 1.5%, more preferably at least 3% and most preferably
at least 6% glutamate by weight of dry matter.
[0052] The monosaccharide content of the crude umami fraction preferably is less than 20%, more preferably less
than 10%, even more preferably les than 5% and most preferably less than 3% by weight of dry matter.
[0053] The weight fraction Y (glutamate:monosaccharide) of the monosaccharide fraction typically is less than 0.1,
more preferably less than 0.01 and most preferably less than 0.003.
[0054] The monosaccharide fraction typically has a weight ratio citrate:monosaccharide of less than 0.01, more pref-
erably of less than 0.005.
[0055] The monosaccharide content of the monosaccharide fraction preferably is at least 80% by weight of dry matter,
more preferably at least 90% by weight of dry matter and most preferably at least 95% by weight of dry matter.
[0056] In a particularly advantageous embodiment of the invention, at least 90% of the glutamate, at least 80% of the
citrate and less than 10% of the monosaccharide contained in the lycopene-depleted portion is recovered in the crude
umami fraction.
[0057] In the present method the crude umami fraction that is obtained from the chromatographic fractionation of the
lycopene depleted portion typically has a Brix value of 2-20° Brix, more preferably of 3-12° Brix. The monosaccharide
fraction typically has a Brix value of 4-30°, especially 6-20° Brix.








• 0-40% of other tomato components.
[0059] The crude umami fraction that is used as feed for the second chromatographic fractionation step may optionally
be concentrated beforehand. Preferably, the crude umami fraction is concentrated to a Brix value of at least 8°, more
preferably 15-40° Brix prior to the second chromatographic separation step.
[0060] The clean umami fraction obtained from the second chromatographic separation step typically comprises by
weight of dry matter:
• 6-75%, preferably 10-45% glutamate;
• 0-10%, preferably 0.5-6% 5’-AMP;
• 1-25%, preferably 2-20% aspartate;
• 0-20%, preferably 0-10% citrate;
• 0-10%, preferably 0-5% monosaccharides;
• 0.1-15%, preferably 0.5-15% sucrose; and
wherein the weight ratio glutamate:citrate exceeds 2 and wherein glutamate, 5’-AMP, aspartate and pyroglutamate
together represent at least 15%, preferably at least 25% and most preferably at least 35% by weight of the dry matter
contained in the tomato isolate.
[0061] For the second chromatograph fractionation step, ion exclusion chromatography or ion exclusion chromatog-
raphy may advantageously be used.
[0062] The second fractionation step serves to further increase the amounts of desirable compounds relative to un-
desirable compounds. In the second fractionation step a clean umami fraction with a weight ratio K (glutamate:citrate)













and a citrate fraction with a weight ratio L (glutamate:citrate) are obtained, wherein the ratio K:L exceeds 50, more
preferably exceeds 100 and most preferably exceeds 500.
[0063] The benefits of the present invention are particularly pronounced in case the second fractionation is carried
out such that K is at least 2, more preferably of at least 3 and most preferably of at least 6.
[0064] The ratio L achieved in the citrate fraction preferably is less than 0.1, more preferably less than 0.05 and most
preferably less than 0.01.
[0065] Typically, at least 60% of the glutamate, more preferably at least 80% of the glutamate contained in the crude
umami fraction is recovered in the clean umami fraction.
[0066] The glutamate content of the clean umami fraction typically exceeds 6% by weight of dry matter, more preferably
10% by weight of dry matter and most preferably 15% by weight of dry matter.
[0067] The present method enables the production of a clean umami fraction with a low citrate content. Typically, less
than 10% of the citrate contained in the crude umami fraction is recovered in the clean umami fraction.
[0068] The clean umami fraction typically contains not more than 30% citrate by weight of dry matter, more preferably
not more than 20% citrate by weight of dry matter, most preferably not more than 10% citrate by weight of dry matter.
[0069] The umami characteristics of the clean umami fraction obtained by the present method were found to benefit
from the presence of 5’nucleoside monophosphates. Thus, the chromatographic fractionations are preferably carried
out in such a way that a substantial fraction of the 5’nucleoside monophosphates present in the tomato serum end up
in the clean umami fraction. Of the 5’nucleoside monophosphates found in tomato, 5’adenosine monophosphate (5’AMP)
is most abundant. Preferably, the clean umami fraction contains at least 0.3%, more preferably at least 0.8% and most
preferably at least 1.7% of 5’-AMP by weight of dry matter.
[0070] The present method enables glutamate to be isolated from tomato serum in high yield. Typically, at least 70%
of the glutamate contained in the tomato serum is recovered in the clean umami fraction. More preferably at least 75%
and most preferably at least 80% of the glutamate contained in the tomato serum is recovered in the cleam umami fraction.
[0071] The citrate fraction that is produced by the second chromatographic fractionation step preferably contains at
least 20%, more preferably at least 25% and most preferably at least 30% citrate by weight of dry matter.
[0072] The glutamate content of the citrate fraction typically is less than 2% by weight of dry matter, more preferably
less than 1.5% by weight of dry matter and most preferably less than 1.0% by weight of dry matter.
[0073] In the present method the clean umami fraction that is obtained from the chromatographic fractionation of the
crude umami fraction typically has a Brix value of 0.3-20° Brix, more preferably of 0.5-12.5° Brix. The citrate fraction
typically has a Brix value of 0.3-20°, especially 0.5-12.5° Brix.
[0074] The chromatographic fractionation of the lycopene depleted portion and the crude umami fraction is suitably
carried out using simulated moving bed chromatography.
[0075] Another aspect of the present invention relates to a tomato isolate comprising 0-90 wt.% water and 10-100
wt.% dry matter, said dry matter comprising:
• 6-75%, preferably 10-45% glutamate;
• 0-10, preferably 0.5-6% 5’-AMP;
• 1-25%, preferably 2-20% aspartate;
• 0-20%, preferably 0-10% citrate;
• 0-10%, preferably 0-5% monosaccharides;
• 0.1-15%, preferably 0.5-15% sucrose; and
wherein the weight ratio glutamate:citrate exceeds 2 and wherein glutamate, 5’-AMP, aspartate and pyroglutamate
together represent at least 15 wt.%, preferably at least 25 wt.% and most preferably at least 35 wt.% of the dry matter
contained in the tomato isolate.
[0076] Advantageously, the isolate is an optionally dehydrated clean umami fraction obtained using the isolation
method of the present invention.
[0077] The tomato isolate of the present invention typically contains at least 10% potassium, more preferably at least
12% and most preferably 15-40% potassium by weight of dry matter
[0078] According to a preferred embodiment, the weight ratio glutamate:citrate in the present tomato isolate exceeds
3, more preferably it exceeds 6 and most preferably it exceeds 10. The weight ratio glutamate:monosaccharides of the
tomato isolate preferably exceeds 5, more preferably it exceeds 8 and most preferably it exceeds 15..
[0079] In accordance with a further embodiment, the weight ratio 5’-AMP:glutamate in the present tomato isolate lies
within the range of 0.02 to 0.5, preferably of 0.05 to 0.3.
[0080] Advantageously, the 5’-nucleoside monophosphates contained in the tomato isolate are composed of at least
60 wt.% 5’-AMP;less than 10 wt.% 5’-UMP; and less than 10 wt.% GMP.
[0081] The tomato isolate according to the present invention typically has a Brix value of at least 20° Brix, more
preferably of at least 40° Brix, most preferably of at least 60° Brix.













[0082] The present tomato isolate may suitably be converted into a powder by combining it with a carrier material and
drying the resulting mixture, e.g. by means of spray drying or drum drying. Examples of carrier materials that may suitably
employed include sodium chloride, maltodextrin, starches and combinations thereof. Most preferably, the carrier material
employed is sodium chloride. Typically, the carrier material is combined with the tomato isolate in an amount that equates
30-50 wt.%, more preferably 10- 25 wt.% of the dry matter contained in the tomato isolate.
[0083] Yet another aspect of the invention relates to a process for manufacturing a foodstuff or a beverage, said
process comprising combining a tomato isolate according to the invention with one or more other ingredients so as to
provide glutamate in an amount of at least 0.01% by weight of the foodstuff or beverage. In the present process the
tomato isolate may be introduced as such; in the form of a pre-blend with one or more other ingredients; or in the form
of a powder that is obtained by the drying method described herein before.
[0084] The benefits of the present process are particularly appreciated in case the tomato isolate is employed in a
foodstuff or beverage that contains tomato ingredients other than the tomato isolate. Accordingly, in a preferred embod-
iment, such a foodstuff or beverage contains at least 1%, more preferably at least 20% and most preferably at least 35%
tomato solids other than the tomato isolate by weight of dry matter. Examples of foodstuffs or beverages containing
tomato ingredients include ketchup, tomato soup, tomato sauce and tomato juice. Disclosed herein is a foodstuff or a
beverage obtained by the process described above. Preferably, said foodstuff or beverage is selected from ketchup,
tomato soup, tomato sauce and tomato juice.
[0085] The invention is further illustrated by the following non-limiting examples.
Examples
Example 1
[0086] A hot break tomato juice was subjected to solids removal using a decanter and centrifuge followed by lycopene
removal using an ultra-filtration process.
[0087] Fresh hot break juice (4.5°Bx and 75°C) was decanted in a NX416 decanter (Alfa Laval) at 3150 rpm (diff speed
63Hz, 2080 G) to produce a fibre fraction and clarified juice in a weight ratio of approximately 1:10. The clarified juice
was centrifuged in a high speed separator (Clara 80, Alfa Laval) to remove a small fraction (appr. 0.02 wt.%) of insoluble
solids. The double clarified juice so obtained did not contain detectable spin solids).
[0088] The double clarified juice was separated over a Spiral Ultra Filtration Module 3X3X6338/80 with a GR60PP
membrane (run at VCF 6) to yield 1 part of retentate and 5 parts of permeate. The retentate (lycopene-enriched portion)
contained 101mg/kg lycopene, whereas the permeate (lycopene-depleted portion contained less than 1 mg/kg lycopene.
Example 2
[0089] The lycopene-depleted portion obtained by the procedure described in Example 1 was subjected to IEX chro-
matography to remove Ca and Mg.
[0090] The lycopene-depleted portion was concentrated to 40°Bx before being loaded onto a set of 4 200X3000mm
steel Exchange columns in a 2 by 2 configuration using pilot scale ion exchange equipment (Unipektin Engineering AG,
Eschenz Switzerland). The columns with a bed volume of 75 L each were filled with ion exchange resin (Lewatit S-2568,
LanXess K+-form). The lycopene-depleted portion was followed by demi-water eluent. The combined streams were
collected and yielded 290 L of calcium and magnesium depleted material with an average concentration of 8.7°Bx.
[0091] The composition of the lycopene-depleted portion before and after IEX treatment is shown in Table.
Example 3
[0092] The lycopene-depleted portion that had been subjected to the IEX treatment described in Example 2 was
concentrated to 39.5 °Bx and subsequently separated into a crude umami fraction and a monosaccharide fraction by
means of Simulated Moving Bed (SMB) chromatography.
[0093] 45.4 L of the concentrate was fed to the feed port of an SMB apparatus. At the same time 390.7 L of demineralised
water was fed to the eluent port. The SMB equipment contained a CSEP® C9116 32 port rotary valve (Knauer GmbH,
Table 1
Sample [Ca] mmol/kg DM [Mg] mmol/kg DM
Before IEX treatment) 21 77
After IEX treatment 0.4 5.3













Berlin, Germany) that was connected to 8 chromatography columns creating 4 separation zones.
[0094] Four pumps were controlling the flows in each zone. The SMB equipment was operated in open loop mode,
creating a third stream. The columns having dimensions 210*50 mm were packed with Diaion™ UBK-530 resin in the
K-form.
[0095] While constantly feeding and eluting the columns, two product streams were collected:
• 164.9 L of a raffinate stream (crude umami fraction) from zone 3 with an average concentration of 5.0 °Bx; and
• 130.2 L of an extract stream (monosaccharide fraction) from zone 2 with an average concentration of 9.5°Bx
[0096] The compositions of the feed, the monosaccharide fraction and the crude umami fraction are depicted in Table 2.
Example 4
[0097] The crude umami fraction obtained by the procedure described in Example 3 was subjected to another SMB
chromatographic separation to yield a clean umami fraction and a citrate fraction.
[0098] 2.8 L crude umami fraction that had been preconcentrated to 21.5 °Bx was fed to the feed port of the same
SMB apparatus as used in Example 3. At the same time 81.0 L of deminerelised water was fed to the eluent port. The
SMB equipment was again operated in open loop mode.
[0099] While constantly feeding and eluting the columns, two product streams were collected:
• 40.0 L of a raffinate stream (citrate rich fraction) from zone 3 with an average concentration of 1.1 °Bx; and
• 28.1 L of an extract stream (clean umami fraction) from zone 2 with an average concentration of 1.1 °Bx
[0100] The composition of the feed and the two product streams are depicted in Table 3
Table 2
Feed Monosacch. fraction Crude umami fraction
Brix °Bx 39.5 9.5 5.0
Dry matter % 39.0 9.4 5.2
Glucose g/kg 104.2 41.5 <0.4
Fructose g/kg 133.2 54.8 <0.4
Sucrose g/kg 2.0 0.0 0.9
Citric acid g/kg 27.7 <0.4 9.3
Pyroglutamic acid g/kg 14.1 <0.4 4.7
Glutamic acid g/kg 11.6 <0.4 3.9
Aspartic acid g/kg 5.1 <0.4 1.7
Potassium g/kg 34.5 <0.0001 10.8
AMP g/kg 0.96 <0.02 0.32
UMP g/kg 0.37 <0.02 0.16
GMP g/kg <0.02 <0.02 <0.02
CMP g/kg <0.02 <0.02 <0.02
IMP g/kg <0.02 <0.02 <0.02
Table 3
Feed Clean umami fraction Citric fraction
Brix °Bx 21.5 1.1 1.1














[0101] A clean umami fraction obtained by a procedure as described in Examples 1-4 was used to replace a standard
yeast extract in 2 different products:
• Base for vegetable broth
• French vegetable bouillon
[0102] On a dry weight basis 2.75 parts of the standard yeast extract were replaced by 1 part of the clean umami
fraction. Since yeast extract contains salt, an equivalent amount of salt was added together with the clean umami fraction.
[0103] For both the base for vegetable broth and the French vegetable bouillon, the intensity of the ’umami’ taste
attribute was not affected by the replacement of yeast extract by the clean umami extract.
Example 6
[0104] The clean umami fraction obtained by a procedure as described in Examples 1-4 was used to replace mono-
sodium glutamate (MSG) and/or yeast extract in tomato soup.
[0105] The combined amount of MSG and yeast extract in the reference product in relation to tomato solids was 1 to
6.6. The clean umami fraction was applied in an amount, calculated on a dry weight basis of 1 part umami fraction to
16 parts tomato solids.
[0106] Tomato soup was prepared by combining a dry tomato soup base that contained no added MSG or yeast
extract with monosodium glutamate, yeast extract, clean umami fraction (preheated) or a combination of two of these
taste enhancing ingredients. Next, boiling water was added to prepare the soup.
[0107] The intensity of the ’umami’ taste of each of the hot soups was evaluated by an expert panel and ranked (the
higher the score, the higher the intensity). The results are shown in Table 4
[0108] It was found that the addition of the umami fraction also contributed positively to the taste of the tomato soup
in that it imparted fresh tomato character.
(continued)
Feed Clean umami fraction Citric fraction
Dry matter % 21.5 0.8 1.0
Sucrose g/kg 3.2 0.3 ND
Citric acid g/kg 38.9 <0.05 3.7
Pyroglutamic acid g/kg 19.8 1.1 0.8
Glutamic acid g/kg 14.6 1.4 0.1
Aspartic acid g/kg 6.3 0.6 ND
Potassium g/kg 45.0 1.96 2.11
AMP g/kg 1.13 0.14 0.02
UMP g/kg 0.54 0.03 0.02
Table 4
Intensity score
Yeast extract + umami fraction 6.6
MSG + umami fraction 6.3
Umami fraction 6.2
Reference (yeast extract + MSG) 6.0














[0109] A clean umami fraction as described in Example 4 was concentrated by evaporation to 7.0°Bx using a Buchi
rotavapor R220 (75 mbar, 60°C). To the concentrate so obtained NaCl was added as drying aid (approx 20% on DM).
870 g of the concentrate with added salt was dried using a Mini Spray Dryer B290 system of Buchi (Tin 140°C, Tout 75°C,
pump 5.6 g/min).
[0110] The composition of the powder so obtained is depicted in Table 5.
Claims
1. A method for producing an umami-active tomato fraction comprising the steps of:
a. providing a tomato serum having a total solids content of 0.05-30 wt.%;
b. separating the tomato serum into two or more portions, including a lycopene-depleted portion and a lycopene-
enriched portion, the lycopene content of the lycopene-depleted portion being less than 30 wt% of that of the
lycopene-enriched portion, both said lycopene contents being calculated on dry matter;
c. concentrating the lycopene-depleted portion to at least 10°Brix;
d. chromatographically fractionating the concentrated lycopene-depleted portion into two or more fractions,
including a crude umami fraction with a weight ratio glutamate:monosaccharide of X and a monosaccharide
fraction with a weight ratio glutamate:monosaccharide of Y, wherein the ratio X:Y exceeds 20;
e. optionally, concentrating the crude umami fraction;
f. chromatographically fractionating the crude umami fraction into two or more fractions, including a clean umami
fraction with a weight ratio glutamate:citrate of K and a citrate fraction with a weight ratio glutamate:citrate of L,
wherein the ratio K:L exceeds 10.
2. Method according to claim 1, wherein prior to step d), the lycopene-depleted portion is treated to reduce the total
amount of calcium and magnesium ions, calculated on dry matter, with at least a factor 4.
3. Method according to claim 1 or 2, wherein prior to step d), the lycopene-depleted portion is treated to reduce the
total amount of calcium and magnesium ions to less than 50 mmol per kg of dry matter.
































• 0-30% of other tomato components.









• 0-40% of other tomato components.
6. Method according to any one of the preceding claims, wherein the crude umami fraction has a weight ratio cit-
rate:monosaccharide of at least 1 and the monosaccharide fraction has a weight ratio citrate:monosaccharide of
less than 0.01.







• 0.1-15% sucrose; and
wherein the weight ratio glutamate:citrate exceeds 2 and wherein glutamate, 5’-AMP, aspartate and pyroglutamate
together represent at least 15% by weight of the dry matter contained in the tomato isolate.
8. Method according to any one of the preceding claims, wherein the concentrated lycopene-depleted fraction is
chromatographically fractionated using ion exclusion chromatography.
9. Method according to any one of the preceding claims, wherein the crude glutamate fraction is chromatographically
fractionated using ion exclusion chromatography or ion exchange chromatography.
10. A tomato isolate comprising 0-90 wt.% water and 10-100 wt.% dry matter, said dry matter comprising:
• 6-75 wt.% glutamate;
• 0-10 wt.% 5’-AMP;
• 1-25 wt.% aspartate;
• 0-20 wt.% citrate;
• 0-10 wt.% monosaccharides;
• 0.1-15 wt.% sucrose; and
wherein the weight ratio glutamate:citrate exceeds 2 and wherein glutamate, 5’-AMP, aspartate and pyroglutamate
together represent at least 15 wt.% of the dry matter contained in the tomato isolate.
11. Tomato isolate according to claim 10, wherein the weight ratio glutamate:citrate exceeds 3 and the weight ratio
glutamate:monosaccharides exceeds 5.
12. Tomato isolate according to claim 10 or 11, wherein the isolate contains at least 10% potassium by weight of dry
matter.
13. Tomato isolate according to any one of claims 10-12, wherein the isolate is an optionally dehydrated clean umami
fraction obtained from a method according to any one of claims 1-9.













14. A process of manufacturing a foodstuff or a beverage, said process comprising combining a tomato isolate according
to any one of claims 10-13 with one or more other ingredients so as to provide glutamate in an amount of at least
0.01 % by weight of the foodstuff or beverage.
Patentansprüche
1. Verfahren zur Herstellung einer umamiaktiven Tomatenfraktion, das die Schritte umfasst:
a. Bereitstellen eines Tomatenserums mit einem Gesamtfeststoffgehalt von 0,05-30 Gew.-%,
b. Separieren des Tomatenserums in zwei oder mehr Anteile, einschließlich eines Lycopin-abgereicherten
Anteils und eines Lycopin-angereicherten Anteils, wobei der Lycopin-Gehalt des Lycopin-abgereicherten Anteils
weniger als 30 Gew.-% desjenigen des Lycopin-angereicherten Anteils beträgt, wobei beide Lycopin-Gehalte
auf Trockensubstanz berechnet sind,
c. Konzentrieren des Lycopin-abgereicherten Anteils auf mindestens 10°Brix,
d. chromatographisches Fraktionieren des konzentrierten Lycopin-abgereicherten Anteils in zwei oder mehr
Fraktionen, einschließlich einer rohen Umami-Fraktion mit einem Gewichtsverhältnis Glutamat:Monosaccharid
von X und einer Monosaccharid-Fraktion mit einem Gewichtsverhältnis Glutamat:Monosaccharid von Y, wobei
das Verhältnis X:Y 20 überschreitet,
e. optionales Konzentrieren der rohen Umami-Fraktion,
f. chromatographisches Fraktionieren der rohen Umami-Fraktion in zwei oder mehr Fraktionen, einschließlich
einer reinen Umami-Fraktion mit einem Gewichtsverhältnis Glutamat:Citrat von K und einer Citrat-Fraktion mit
einem Gewichtsverhältnis Glutamat:Citrat von L, wobei das Verhältnis K:L 10 überschreitet.
2. Verfahren nach Anspruch 1, wobei vor dem Schritt d) der Lycopin-abgereicherte Anteil behandelt wird, um die
Gesamtmenge von Calcium- und Magnesium-Ionen, berechnet auf Trockensubstanz, mindestens um einen Faktor
4 zu reduzieren.
3. Verfahren nach Anspruch 1 oder 2, wobei vor dem Schritt d) der Lycopin-abgereicherte Anteil behandelt wird, um
die Gesamtmenge von Calcium- und Magnesium-Ionen auf weniger als 50 mmol pro kg Trockensubstanz zu redu-
zieren.
4. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei der Lycopin-abgereicherte Anteil, bezogen auf







• 0,1-3% 5’-Adenosin-Monophosphat (5’-AMP),
• 0-30% andere Tomatenbestandteile.
5. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei die rohe Umami-Fraktion, bezogen auf das








• 0-40% andere Tomatenbestandteile.
6. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei die rohe Umami-Fraktion ein Gewichtsverhält-
nis Citrat:Monosaccharid von mindestens 1 und die Monosaccharid-Fraktion ein Gewichtsverhältnis Citrat:Mono-













saccharid von weniger als 0,01 aufweist.
7. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei die reine Umami-Fraktion, bezogen auf das






• 0,1-15% Sucrose und
wobei das Gewichtsverhältnis Glutamat:Citrat 2 überschreitet und wobei Glutamat, 5’-AMP, Aspartat und Pyroglu-
tamat zusammen mindestens 15 Gewichts-% der Trockensubstanz, die in dem Tomatenisolat enthalten ist, dar-
stellen.
8. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei die konzentrierte Lycopin-abgereicherte Frak-
tion chromatographisch unter Anwendung der Ionenausschlusschromatographie fraktioniert wird.
9. Verfahren nach irgendeinem der vorhergehenden Ansprüche, wobei die rohe Glutamat-Fraktion chromatographisch
unter Anwendung der Ionenausschlusschromatographie oder der Ionenaustauschchromatographie fraktioniert wird.
10. Tomatenisolat, umfassend 0-90 Gew.-% Wasser und 10-100 Gew.-% Trockensubstanz, wobei die Trockensubstanz
umfasst:
• 6-75 Gew.-% Glutamat,
• 0-10 Gew.-% 5’-AMP,
• 1-25 Gew.-% Aspartat,
• 0-20 Gew.-% Citrat,
• 0-10 Gew.-% Monosaccharide,
• 0,1-15 Gew.-% Sucrose und
wobei das Gewichtsverhältnis Glutamat:Citrat 2 überschreitet und wobei Glutamat, 5’-AMP, Aspartat und Pyroglu-
tamat zusammen mindestens 15 Gew.-% der Trockensubstanz, die in dem Tomatenisolat enthalten ist, darstellen.
11. Tomatenisolat nach Anspruch 10, wobei das Gewichtsverhältnis Glutamat:Citrat 3 überschreitet und das Gewichts-
verhältnis Glutamat:Monosaccharide 5 überschreitet.
12. Tomatenisolat nach Anspruch 10 oder 11, wobei das Isolat mindestens 10% Kalium, bezogen auf das Gewicht der
Trockensubstanz, enthält.
13. Tomatenisolat nach irgendeinem der Ansprüche 10-12, wobei das Isolat eine optional dehydratisierte reine Umami-
Fraktion darstellt, die nach dem Verfahren gemäß irgendeinem der Ansprüche 1-9 erhalten wird.
14. Verfahren zur Herstellung eines Lebensmittels oder eines Getränks, wobei das Verfahren das Kombinieren eines
Tomatenisolats nach irgendeinem der Ansprüche 10-13 mit einem oder mehreren anderen Bestandteilen umfasst,
um dadurch Glutamat in einer Menge von mindestens 0,01 Gewichts-% des Lebensmittels oder des Getränks
bereitzustellen.
Revendications
1. Procédé de production d’une fraction de tomate active pour l’umami comprenant les étapes consistant :
a. à fournir un sérum de tomate ayant une teneur totale en matières solides de 0,05-30 % en masse ;
b. à séparer le sérum de tomate en deux portions ou plus, incluant une portion pauvre en lycopène et une
portion riche en lycopène, la teneur en lycopène de la portion pauvre en lycopène étant inférieure à 30 % en
masse de celle de la portion riche en lycopène, les deux dites teneurs en lycopène étant calculées sur la matière














c. à concentrer la portion pauvre en lycopène à au moins 10°Brix ;
d. à fractionner par chromatographie la portion pauvre en lycopène concentrée en deux fractions ou plus,
incluant une fraction d’umami brute avec un rapport massique glutamate:monosaccharide de X et une fraction
de monosaccharide avec un rapport massique glutamate: monosaccharide de Y, où le rapport X:Y excède 20 ;
e. éventuellement, à concentrer la fraction d’umami brute ;
f. à fractionner par chromatographie la fraction d’umami brute en deux fractions ou plus, incluant une fraction
d’umami propre avec un rapport massique glutamate:citrate de K et une fraction de citrate avec un rapport
massique glutamate:citrate de L, où le rapport K:L excède 10.
2. Procédé selon la revendication 1, où avant l’étape d), la portion pauvre en lycopène est traitée pour réduire la
quantité totale d’ions calcium et magnésium, calculée sur une matière sèche, avec au moins un facteur 4.
3. Procédé selon la revendication 1 ou 2, où avant l’étape d), la portion pauvre en lycopène est traitée pour réduire la
quantité totale d’ions calcium et magnésium à moins de 50 mmol par kg de matière sèche.
4. Procédé selon l’une quelconque des revendications précédentes, où la portion pauvre en lycopène contient, en
masse de matière sèche :
• 30-80 % de monosaccharides ;
• 0,5-8 % de saccharose ;
• 2-30 % de citrate ;
• 1,5-20 % de glutamate ;
• 0,4-6 % d’aspartate ;
• 0,5-15 % de pyroglutamate ;
• 0,1-3 % de monophosphate de 5’-adénosine (5’-AMP) ;
• 0-30 % d’autres constituants de tomate.
5. Procédé selon l’une quelconque des revendications précédentes, dans lequel la fraction d’umami brute contient,
en masse de matière sèche :
• 0-20 % de monosaccharides ;
• 0,5-20 % de saccharose ;
• 5-40 % de citrate ;
• 3-40 % de glutamate ;
• 1-10 % d’aspartate ;
• 1-20 % de pyroglutamate ;
• 0,1-5 % de 5’-AMP ;
• 0-40 % d’autres constituants de tomate.
6. Procédé selon l’une quelconque des revendications précédentes, dans lequel la fraction d’umami brute présente
un rapport massique citrate:monosaccharide d’au moins 1 et la fraction de monosaccharide présente un rapport
massique citrate:monosaccharide inférieur à 0,01.
7. Procédé selon l’une quelconque des revendications précédentes, dans lequel la fraction d’umami propre comprend
en masse de matière sèche :
• 6-75 % de glutamate ;
• 0-10 % de 5’-AMP ;
• 1-25 % d’aspartate ;
• 0-20 % de citrate ;
• 0-10 % de monosaccharides ;
• 0,1-15 % de saccharose ; et
où le rapport massique glutamate : citrate excède 2 et où les glutamate, 5’-AMP, aspartate et pyroglutamate repré-
sentent ensemble au moins 15 % en masse de la matière sèche contenue dans l’isolat de tomate.
8. Procédé selon l’une quelconque des revendications précédentes, où la fraction pauvre en lycopène concentrée est













fractionnée par chromatographie en utilisant une chromatographie à exclusion d’ions.
9. Procédé selon l’une quelconque des revendications précédentes, où la fraction de glutamate brute est fractionnée
par chromatographie en utilisant une chromatographie à exclusion d’ions ou une chromatographie à échange d’ions.
10. Isolat de tomate comprenant 0-90 % en masse d’eau et 10-100 % en masse de matière sèche, ladite matière sèche
comprenant :
• 6-75 % en masse de glutamate ;
• 0-10 % en masse de 5’-AMP ;
• 1-25 % en masse d’aspartate ;
• 0-20 % en masse de citrate ;
• 0-10 % en masse de monosaccharides ;
• 0,1-15 % en masse de saccharose ; et
où le rapport massique glutamate : citrate excède 2 et où les glutamate, 5’-AMP, aspartate et pyroglutamate repré-
sentent ensemble au moins 15 % en masse de la matière sèche contenue dans l’isolat de tomate.
11. Isolat de tomate selon la revendication 10, où le rapport massique glutamate : citrate excède 3 et le rapport massique
glutamate : monosaccharides excède 5.
12. Isolat de tomate selon la revendication 10 ou 11, où l’isolat contient au moins 10 % de potassium en masse de
matière sèche.
13. Isolat de tomate selon l’une quelconque des revendications 10-12, où l’isolat est une fraction d’umami propre
éventuellement déshydratée obtenue à partir d’un procédé selon l’une quelconque des revendications 1-9.
14. Procédé de fabrication d’un aliment ou d’une boisson, ledit procédé comprenant la combinaison d’un isolat de tomate
selon l’une quelconque des revendications 10-13 avec un ou plusieurs autres ingrédients afin de fournir du glutamate
dans une quantité d’au moins 0,01 % en masse de l’aliment ou de la boisson.
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